Skip to main content
. 2020 Apr 7;23(2):115–128. doi: 10.4048/jbc.2020.23.e24

Table 3. Molecular subtype of newly diagnosed breast cancer in 2017 in Korea (KBCS registry data).

Molecular subtype No. of patients
HR (+), HER2 (−) 6,377 (65.9)
HR (+), HER2 (+) 1,133 (11.7)
HR (−), HER2 (+) 981 (10.2)
HR (−), HER2 (−) 1,183 (12.2)
Total 9,674 (100.0)

Values are presented as number (%).

KBCS = Korean Breast Cancer Society; HR = hormone receptor; HER2 = human epidermal growth factor receptor-2.